Your email has been successfully added to our mailing list.

×
0 0 0 -0.0962025316455696 -0.0784810126582279 -0.131645569620253 -0.139240506329114 -0.121518987341772
Stock impact report

FDA accepts Verastem's marketing application for blood cancer med duvelisib, action date October 5; shares up 33% premarket [Seeking Alpha]

Verastem, Inc. (VSTM) 
Last verastem, inc. earnings: 10/29 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: verastem.com
Company Research Source: Seeking Alpha
FDA accepts Verastem's marketing application for blood cancer med duvelisib, action date October 5; shares up 33% premarketThe FDAaccepts under Priority Review Verastem's (NASDAQ:VSTM) marketing application seeking approval for duvelisib for the treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and accelerated approval for relapsed/refractory follicular lymphoma (FL).The agency's action date is October 5.Shares are up33% premarket on light volume.Previously:Verastem submits U.S. marketing application for lead candidate duvelisib; shares ahead 7% premarket (Feb. 7)See all stocks on the move »Now read:3 Things In Biotech You Should Learn Today: February 9, 2018 » Show less Read more
Impact Snapshot
Event Time:
VSTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
VSTM alerts

from News Quantified
Opt-in for
VSTM alerts

from News Quantified